The diagnosis of human T-cell leukemia virus type-1 (HTLV-1) infection has been widely examined by serologics. In the first screening tests, serological false negative and positive samples have been reduced thanks to advances in assay techniques that apply new emission agents and sensors. On the other hand, western blot (WB) remains problematic. For example, WB analysis yields many samples equivalent to antibody positive ones. To reduce the need for WB, an alternative testing strategy is required to detect HTLV-1 infection. Polymerase chain reaction (PCR) for the HTLV-1 provirus has recently been recommended for a final diagnosis of infection. However, although PCR is thought to be one element, the validation of detection performance for HTLV-1 infection between serological and molecular testing is not always clear. Thus, this study aimed to evaluate the accuracy and test the validity of an improved methodology for serological detection of HTLV-infection, as well as that of PCR. In conclusion, the high values of kappa-statistics are expected to deliver high quality in chemiluminescent enzyme immunoassay (or chemiluminescent immunoassay), while the problems with WB assays remain to be elucidated. As an alternative to WB, a combination of real-time qPCR and nested PCR is proposed as a suitable confirmatory test.
were used. During this period, 9,718 samples were tested for screening. 105 samples 25 excluding double negative in PA and CLEIA samples were used as the secondary 26 samples, and were examined for infection by 4 methods as described below. Meanwhile, 27 using 25 practical blood samples collected from hospitalized patients in complete 28 remission from adult T-cell leukemia (ATL), the role of PCR in serological detection of 29
HTLV-1 infection was investigated. 30
Next, we examined low titer samples or sero-negative converted samples selected from HTLV-1 provirus-integrated cells (Table 2) . Thus, the condition of gp46 positivity in the 72 WHO criteria may not be ideal. 73
The value of kappa-statistics concerning the validation of test performance in a 74 combination of the two methods is summarized in Table 3 . The two chemi-luminescent 75 immune assays (CLEIA and CLIA) kits were evaluated to be excellent. 76 77 2. The role of PCR in the serological diagnostic strategy of HTLV-1 infection 78
About half the cases with sero-indeterminate WB patterns had negative or low titers in 79 other assays. Accordingly, we examined whether the HTLV-1 provirus could be detected 80 in low titer samples or sero-negative converted samples selected from 350 ATL patients 81 who underwent bone marrow transplantation (BMT) and/or chemotherapy. As shown in 82 Table 4 , PVL was 0 to 0.5% in 25 of the 350 samples, consisting of 14 sero and 83 molecular positive samples (group Ⅰ ), 7 negative qPCR samples with or without 84 sero-positivity (group Ⅱ), and 4 sero-negative and qPCR(-) ･nPCR(+) or (-) samples 85 (group Ⅲ). This means that serological detection of HTLV-1 infection is better than 86 qPCR for blood samples with a PVL of less than around 0.4%. However, if the detection 87 sensitivity of qPCR was supplemented with nPCR, such molecular methods gave high 88 detection rates. No sample was nPCR(-) and sero-positive. The value of 89 kappa-statistics in the combination of qPCR and CLEIA was 0.545 and the combination 90 of qPCR or nPCR and CLEIA was 0.744, respectively. These findings indicate we 91 should use qPCR or nPCR and CLEIA when we test unnatural samples collected in the 92 complete remission state after BMT and/or chemotherapy in patients with ATL. The 93 discrepancy between the provirus by qPCR and anti-body by CLEIA seems to be relatedto the detection sensitivity. 95
Since the discovery that HTLV-1 is causative for ATL as well as HAM/TSP 15 transmission is important. The natural transmission route is known mainly to beWB was the worst performer; no validity as a confirmatory test was found. The reason 118 for this appears to result be presence of many sero-indeterminates (14.3%) in endemic 119 erea(Nagasaki). Additionally, the present study indicated that 60 to 70% of WB 120
indeterminates were probably positive, in particular in cases with no gp46 band. Taken 121 together, the CLEIA (and/or CLIA) is probably suitable for the first screening, but there 122 seems to be no appropriate serological test as a confirmatory test. 123
Moreover, when serological assays yield discrepant results, no one knows which 124 result is correct. From biological and confirmatory points of view, the genetic approach 125 is promising and attractive. Thus, we compared test and diagnostic performance of 126 PCR and serological assays. Although the benefits of real-time qPCR are well 127 understood, as summarized schematically in Figure 2 , the detection limit of 0.01% is a 128 disadvantage of this technology. However, since a combination with nPCR became 129 sensitive at 0.001%, nPCR(-) may be thought of as un-infected. Currently, the 130 pathological significance in such a very low number of infected cells remains to be 131 elucidated. In general, the limit of detection of qPCR is thought to be 0.01 to 132 0.5% 13,23-27 ） , the same as with our method. If we convert 0.01% of PVL into total 133 infected cells per body, a total of 3 x 10 -4~-5 infected cells exist within the whole body, 134
indicating that such an infected cell burden seems to be natural in the production of 135 anti-HTLV-1 antibodies. Since even some samples with qPCR(-) and nPCR(+) were 136 positive for the antibody, real-time qPCR may yield seropositive individuals carrying a 137 small number of infected cells detected by only nPCR. This suggests that a 138 combination of qPCR and nPCR is a better algorithm as a confirmatory test. 139
In conclusion, the high values of kappa-statistics are expected to deliver high Table 1 . 261
The HTLV-1 serological results of 105 pregnant sera by each method. 262
The positive rate was significantly lower in WB compared to other 3 methods (<.05) with 263 high indeterminates in 15 sera. Table 3 . 272
The proportional agreement and kappa-statistic between the two methods. 
